Features For Use Under an Emergency Use Authorization (EUA) Only: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-antigen-diagnostic-tests-sars-cov-2 Product ships with minimum 30 days dating The QuickVue At-Home OTC COVID-19 Test is intended for the qualitative detection...
Features The Sofia RSV Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral-flow technology to detect respiratory syncytial virus (RSV) nucleoprotein antigen directly from nasopharyngeal swab and nasopharyngeal aspirate/wash specimens All components...
Features The Sofia Influenza A+B FIA employs immunofluorescence to detect influenza A and influenza B viral nucleoprotein antigens in nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash specimens taken directly from...
Features A single sample can be used to run both the QuickVue RSV test and QuickVue brand Influenza tests 15 minutes to result Built-in internal control Kit includes external controls,...
Features The Solana GAS Assay is a rapid in vitro diagnostic test for the qualitative detection of Group A B-hemolytic Streptococcus (Streptococcus pyogenes) nucleic acids isolated from throat swab specimens...
Provides rapid, quantitative results in approximately 20 minutes The Alere Triage¨ D-Dimer Test is a rapid, quantitative immunoassay to aid in assessing and evaluating patients with suspected disseminated intravascular coagulation...
The Triage BNP test measures BNP to aid in the diagnosis and assess the severity of congestive heart failure The test is also used for the risk stratification of patients...
